Targeting mutated GTPase KRAS in tumor therapies
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference139 articles.
1. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: hopes and realities;Bournet;Eur. J. Canc.,2016
2. The clinical relevance of KRAS gene mutation in non-small-cell lung cancer;Tímár;Curr. Opin. Oncol.,2014
3. Targeting the tumor microenvironment: an unexplored strategy for mutant KRAS tumors;Carvalho;Cancers,2019
4. High resolution crystal structure of a KRAS promoter G-quadruplex reveals a dimer with extensive poly-A π-stacking interactions for small-molecule recognition;Ou;Nucleic Acids Res.,2020
5. Exploiting RAS nucleotide cycling as a strategy for drugging RAS-driven cancers;Mattox;Int. J. Mol. Sci.,2019
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19;Frontiers in Immunology;2024-09-06
2. The proteomic analysis uncovers the cellular responses to the African swine fever virus membrane proteins p54, p17, and pB117L;Microbes and Infection;2024-07
3. Small molecular inhibitors: Therapeutic strategies for pancreatic cancer;Drug Discovery Today;2024-07
4. Early pharmacological profiling of isatin derivatives as potent and selective cytotoxic agents;Biochemical Pharmacology;2024-04
5. Enzyme inhibitors for drug discovery;Amino Acids;2023-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3